Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CAD 379.36 billion. The enterprise value is 435.69 billion.

Market Cap	379.36B
Enterprise Value	435.69B

Important Dates

The next confirmed earnings date is Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	Mar 11, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.80%
Shares Change (QoQ)	-0.67%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	43.83%
Float	1.82B

Valuation Ratios

The trailing PE ratio is 20.08 and the forward PE ratio is 16.19.

PE Ratio	20.08
Forward PE	16.19
PS Ratio	4.80
PB Ratio	6.98
P/TBV Ratio	n/a
P/FCF Ratio	15.50
P/OCF Ratio	14.17
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.51, with an EV/FCF ratio of 17.80.

EV / Earnings	23.06
EV / Sales	5.54
EV / EBITDA	13.51
EV / EBIT	17.02
EV / FCF	17.80

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 1.21.

Current Ratio	0.85
Quick Ratio	0.53
Debt / Equity	1.21
Debt / EBITDA	2.03
Debt / FCF	2.68
Interest Coverage	15.14

Financial Efficiency

Return on equity (ROE) is 34.93% and return on invested capital (ROIC) is 21.10%.

Return on Equity (ROE)	34.93%
Return on Assets (ROA)	10.54%
Return on Invested Capital (ROIC)	21.10%
Return on Capital Employed (ROCE)	21.14%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.05M
Profits Per Employee	250,994
Employee Count	75,267
Asset Turnover	0.52
Inventory Turnover	2.28

Taxes

In the past 12 months, Novartis AG has paid 3.17 billion in taxes.

Income Tax	3.17B
Effective Tax Rate	14.38%

Stock Price Statistics

The stock price has increased by +24.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+24.68%
50-Day Moving Average	28.79
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.25
Average Volume (20 Days)	21,205

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CAD 78.97 billion and earned 18.89 billion in profits. Earnings per share was 9.74.

Revenue	78.97B
Gross Profit	59.67B
Operating Income	25.72B
Pretax Income	22.03B
Net Income	18.89B
EBITDA	32.00B
EBIT	25.72B
Earnings Per Share (EPS)	9.74

Balance Sheet

The company has 9.62 billion in cash and 65.60 billion in debt, giving a net cash position of -55.98 billion.

Cash & Cash Equivalents	9.62B
Total Debt	65.60B
Net Cash	-55.98B
Net Cash Per Share	n/a
Equity (Book Value)	54.34B
Book Value Per Share	28.17
Working Capital	-6.65B

Cash Flow

In the last 12 months, operating cash flow was 26.77 billion and capital expenditures -2.29 billion, giving a free cash flow of 24.48 billion.

Operating Cash Flow	26.77B
Capital Expenditures	-2.29B
Depreciation & Amortization	6.16B
Net Borrowing	19.87B
Free Cash Flow	24.48B
FCF Per Share	n/a

Margins

Gross margin is 75.55%, with operating and profit margins of 32.56% and 23.92%.

Gross Margin	75.55%
Operating Margin	32.56%
Pretax Margin	27.90%
Profit Margin	23.92%
EBITDA Margin	40.51%
EBIT Margin	32.56%
FCF Margin	30.99%

Dividends & Yields

This stock pays an annual dividend of 0.87, which amounts to a dividend yield of 3.15%.

Dividend Per Share	0.87
Dividend Yield	3.15%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	64.15%
Buyback Yield	3.80%
Shareholder Yield	6.94%
Earnings Yield	4.98%
FCF Yield	6.45%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.27 and a Piotroski F-Score of 5.

Altman Z-Score	3.27
Piotroski F-Score	5